Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q6RD31 (Q6RD31_SARS) SARS coronavirus TW3

Spike glycoprotein UniProtKBInterProInteractive Modelling

1255 aa; Sequence (Fasta) ; 26 identical sequences

Available Structures

75 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles Heteromer
P59594; Q9BYF1;
18-1129
NAG;NAG; 11×NAG;NAG;
Assess
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) Heteromer
P59594;
18-1127
27×NAG;NAG;NAG;NAG; 17×NAG;
Assess
Structure of the SARS-CoV spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fr… Heteromer
P59594;
18-1127
12×NAG;NAG;NAG; 36×NAG;
Assess
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) Heteromer
P59594;
18-1127
21×NAG;NAG;NAG;NAG; 16×NAG;
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594; Q9BYF1;
18-1119
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594; Q9BYF1;
18-1119
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594; Q9BYF1;
18-1119
Assess
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047 Heteromer
P59594;
35-1129
47×NAG;
Assess
Structure of a proteolitically resistant core from the severe acute respiratory syndrome coronaviru… Heteromer
P59594;
896-1183
GOL;
Assess
Crystal structure of the SARS-CoV Spike protein fusion core Heteromer
P59594;
901-1185
Assess
A structure-based mechanism of SARS virus membrane fusion Heteromer
P59594;
901-1182
NA;
Assess
Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronaviru… Heteromer
P59594;
914-1193
Assess
Crystal structure of nanobody Nb70 with SARS-CoV RBD Heteromer
P59594;
321-516
NAG;
Assess
Crystal structure of SARS-CoV receptor binding domain in complex with human antibody BIOLS56 Heteromer
P59594;
318-513
NAG;
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P0DTC2; P59594; Q9BYF1;
321-513
NAG;NAG;ZN;CL;EDO;NAG;
Assess
Crystal structure of chimeric omicron RBD (strain XBB.1) complexed with human ACE2 Heteromer
P59594; Q9BYF1;
321-513
NAG;NAG;ZN;CL;EDO;NAG;
Assess
Crystal structure of chimeric omicron RBD (strain XBB.1.5) complexed with human ACE2 Heteromer
P59594; Q9BYF1;
321-513
NAG;NAG;ZN;CL;NAG;
Assess
Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody Heteromer
P59594; Q8N355;
321-512
PO4;NAG;
Assess
Crystal structure of SARS-CoV RBD and horse ACE2 Heteromer
F6V9L3; P59594;
321-512
NAG;NAG;
Assess
Crystal structure of SARS spike protein receptor binding domain in complex with a neutralizing anti… Heteromer
P59594; Q65ZC9;
319-509
CL;
Assess
Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 Heteromer
P59594;
323-513
NAG;PO4;NAG;
Assess
Cryo-EM structure of SARS-CoV spike protein in complex with three nAbs X01, X10 and X17 Heteromer
P59594;
320-508
NAG;
Assess
Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH… Heteromer
P59594;
321-502
NAG;
Assess
Structure of the SARS-CoV receptor binding domain in complex with the human neutralizing antibody F… Heteromer
P59594;
321-502
NAG;
Assess
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2 Heteromer
A0A452CBT6; P59594;
321-502
ZN;
Assess
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with sea lion ACE2 Heteromer
A0A6J2EID0; P59594;
321-502
ZN;
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … Heteromer
P59594; Q9BYF1;
323-502
ZN;CL;
Assess
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor Heteromer
P59594; Q9BYF1;
323-502
NAG;NAG;ZN;CL;
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; Q9BYF1;
323-502
ZN;CL;
Assess
X-ray crystal structure of the SARS coronavirus spike receptor binding domain in complex with F26G1… Heteromer
P59594; Q7TS98; Q8CGS2;
323-502
Assess
Local CryoEM structure of the SARS-CoV S2P in complex with BD55-3152 Fab Heteromer
P59594;
323-502
NAG;NAG;
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… Heteromer
P59594; Q56NL1; Q9BYF1;
324-502
NDG;ZN;CL;NAG;
Assess
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… Heteromer
P59594; Q56NL1; Q9BYF1;
324-502
NDG;ZN;CL;NAG;
Assess
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… Heteromer
P59594; Q56NL1; Q9BYF1;
324-502
ZN;CL;
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; Q56NL1; Q9BYF1;
324-502
ZN;CL;
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… Heteromer
P59594; Q56NL1; Q9BYF1;
324-502
NDG;ZN;CL;NAG;
Assess
Cryo-EM structure of SARS-CoV RBD in complex with rabbit ACE2 Heteromer
G1TEF4; P59594;
329-500
ZN;
Assess
Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1 Heteromer
P59594;
892-968
Assess
A structure-based mechanism of SARS virus membrane fusionhomo-4-mer1150-1187
CL;
Assess
SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformationhomo-3-mer18-1120
NAG;NAG;NAG; 15×NAG;
Assess
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformationhomo-3-mer18-1120
19×NAG;NAG;NAG;NAG;
Assess
SARS Spike Glycoprotein, Stabilized variant, C3 symmetryhomo-3-mer18-1120
NAG;NAG; 18×NAG;
Assess
SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetryhomo-3-mer18-1120
NAG;NAG;NAG; 15×NAG;
Assess
SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformationhomo-3-mer18-1120
NAG;NAG;NAG;NAG; 12×NAG;
Assess
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformationhomo-3-mer18-1120
NAG;NAG;NAG; 13×NAG;
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conforma…homo-3-mer18-1119
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conforma…homo-3-mer18-1119
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conf…homo-3-mer31-1125
NAG; 42×NAG;BLA;EIC;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Confor…homo-3-mer31-1123
21×NAG;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Co…homo-3-mer31-1123
EIC; 46×NAG;BLA;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Locked-2 Conf…homo-3-mer31-1123
NAG; 39×NAG;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Co…homo-3-mer31-1123
NAG; 39×NAG;BLA;EIC;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-1 Conf…homo-3-mer31-1123
EIC; 42×NAG;BLA;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conf…homo-3-mer31-1123
42×NAG;EIC;
Assess
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformationhomo-3-mer31-1123
32×NAG;
Assess
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Closed Confor…homo-3-mer31-1123
NAG; 37×NAG;
Assess
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Closed Conformationhomo-3-mer31-1121
18×NAG;
Assess
SARS CoV Spike protein, Open conformationhomo-3-mer31-1119
23×NAG;
Assess
Structure of SARS-CoV spike glycoproteinhomo-3-mer33-1120
Assess
Prefusion structure of SARS-CoV spike glycoprotein, conformation 1homo-3-mer18-1104
42×NAG;
Assess
Prefusion structure of SARS-CoV spike glycoprotein, conformation 2homo-3-mer18-1104
Assess
SARS CoV Spike protein, Closed C1 conformationhomo-3-mer30-1105
NAG;EIC; 27×NAG;
Assess
SARS CoV Spike protein, Closed C3 conformationhomo-3-mer30-1105
NAG;EIC; 30×NAG;
Assess
SARS-CoV spike glycoproteinhomo-3-mer261-1058
Assess
Post-fusion structure of SARS-CoV spike glycoproteinhomo-3-mer688-1178
24×NAG;
Assess
Post-fusion hairpin conformation of the sars coronavirus spike glycoproteinhomo-3-mer890-981
CL;
Assess
Solution Structure of the SARS-Coronavirus HR2 Domainhomo-3-mer1141-1193
Assess
A structure-based mechanism of SARS virus membrane fusionhomo-3-mer940-973
Assess
A structure-based mechanism of SARS virus membrane fusionhomo-2-mer926-1181
Assess
Crystal structure of SARS spike protein receptor binding domainhomo-2-mer320-502
Assess
Structure of the N-terminal domain (NTD)of SARS-CoV spike proteinmonomer18-289
NAG;NAG;
Assess
NMR Structure and Localization of a Large Fragment of the SARS-CoV Fusion Protein: Implications in …monomer758-821
Assess
Solution structure of Fusion peptidemonomer770-788
Assess
Solution Structure of Pre Transmembrane domainmonomer1185-1202
Assess
Solution Structure of Internal Fusion Peptidemonomer873-888
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7cn8.1.Ahomo-3-mer0.7215-1126
76.97
Assess
7cwu.1.Gmonomer0.6918-1129
77.72
Assess
7wt7.1.Cmonomer0.6818-1144
NAG;75.94
Assess